tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Erika B-Cure Extends Audit Report Examination Amidst Business Deviations

Story Highlights
Erika B-Cure Extends Audit Report Examination Amidst Business Deviations

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Erika B-Cure ( (IL:BCUR) ) has shared an announcement.

Erika B-Cure has announced a deviation from its regular business operations due to issues with the completion of its auditor’s report for the financial years 2021 and 2022. The company, along with its auditors from EY, is extending the examination of these reports and held a meeting on February 13, 2025, to discuss the matter further. Although the auditor’s report has been signed as of February 15, 2025, it explicitly does not serve as a confirmation of the company’s business operations or financial stability.

More about Erika B-Cure

YTD Price Performance: 0.42%

Average Trading Volume: 119,193

Current Market Cap: ILS24.79M

See more data about BCUR stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1